Lv11
90 积分 2023-07-20 加入
Long-Term Experience with Luspatercept in Relapsed/Refractory Myelodysplastic Neoplasms: A Chinese Real-World Study
8小时前
待确认
2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management
8天前
已完结
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT
9天前
已完结
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group
10天前
已完结
Current myeloproliferative neoplasm scoring systems for clinical practice
11天前
已完结
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group
11天前
已完结
Recent advances in JAK2 inhibition for the treatment of myelofibrosis
13天前
已完结
Novel Janus-kinase (JAK) Inhibitors in Myelofibrosis
1个月前
已完结
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
1个月前
已完结
Abstract 779: Blockade of the IL-6/JAK/STAT3 signaling pathway inhibits pancreatic tumor cell growth in 3D spheroid cultures and in xenograft models
1个月前
已关闭
皖公网安备34019202002308
